$AUNA

Zamora Leon Jesus purchased $196K of AUNA (indirect holdings)

Zamora Leon Jesus (President) purchased 45,034 indirectly-held shares of AUNA S.A. (AUNA) at an average of $4.34 ($4.17–$4.39, $0.20M total) across 3 trades over 2026-05-20 to 2026-05-28.

Original reporting
SEC EDGAR · Zamora Leon Jesus
Published Jun 2, 2026, 12:48 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AUNA
Neutral
medium confidence
Mentioned
$AUNA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AUNANeutralLow
01

Why it matters

The insider buy adds a modest positive signal but is unlikely to move the stock significantly.

02

Market read

Small insider purchase; modest relevance for short‑term traders.

03

What to watch

Potential upcoming corporate actions or strategic moves not disclosed yet.

Relevance 5/10Novelty 4/10Timing: after market close on filing day

Background

Form 4 filings disclose insider trades; this is the first public report of this purchase.

Company-level read

Ticker impact

$AUNANeutralMedium confidence
Context

President Zamora Leon Jesus bought 45,034 shares for $195.7K, raising his stake to 55,134 shares.

Expected impact

slight upward pressure as market digests insider buying.

Evidence & confidence

The transaction size is modest relative to market cap, but insider buying is a positive signal.

Market effects

Minimal impact on healthcare sector; insider activity is company‑specific.

Limited to Chilean/Latin American investors tracking AUNA.

Low global relevance.

Counterpoint

The purchase may be routine portfolio rebalancing, not a strong bullish cue.

Key entities

  • Zamora Leon Jesus

    President of AUNA S.A., officer and director.

  • AUNA S.A.

    Healthcare services provider listed on NYSE.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,

$AUNAMed

Auna S.A. Q2 2026 Earnings Call Summary

Auna S.A. reported Q2 2026 revenue growth of 9%, driven by high-complexity services, with adjusted EBITDA declining 9% due to investment costs. Management reaffirmed full-year revenue guidance of 12% growth and expects EBITDA growth at the low end of 10-14%. Free cash flow increased 181% due to working capital management. The company faces short-term penalties in Peru but anticipates improvements in profitability and cash flow.

$AUNAMedAI 9/10

Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q2 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea